Abstract
We decided to continue antimicrobials just to be on the safe side” is a phrase one often hears when a patient with a severe disease is being treated. The words are not always those of an inexperienced physician in training, but those of a senior consultant. The flaw in the rationale behind this is the presumption that a longer course will benefit the patient more than a short course. Sometimes this holds true, but usually it does not. A spectacular example is meningococcal meningitis in which more than one prospective study shows that a single injection of long-acting penicillin, chloramphenicol, or in more recent studies, cephalosporin cures the great majority of patients [1, 2]. However, this regimen should certainly not be tried for other types of bacterial meningitis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
MacFarlane JT, Anjorin FI, Cleland PG, Hassan-King M, Tor-Agbidye S, Wali SS et al. Single injection treatment of meningococcal meningitis. 1. Long-acting penicillin. Transact R Soc Trop Med Hyg 1979;73(6):693–697.
Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study. Lancet 2005;366(9482):308–313.
Kenney W. The prognosis in acute hematogenous osteomyelitis with and without chemotherapy. Surgery 1944;16:477–484.
Emslie KR, Nade S. Acute hematogenous staphylococcal osteomyelitis: the effects of surgical drilling and curettage in an animal model. Pathology 1986;18 (2):227–233.
Wilensky AO. The pathogenesis of the end results of the lesions of acute osteomyelitis. Ann Surgery 1926;84(5):651–662.
Penberthy GC, Weller CN. Chemotherapy as an aid in the management of acute osteomyelitis. Ann Surg 1941;114(1):129–146.
Compere EL, Schnute WJ, Cattell LM. The use of penicillin in the treatment of acute hematogenous osteomyelitis in children: report of twelve consecutive cases. Ann Surg 1945;122(6):954–962.
Carek PJ, Dickerson LM, Sack JL. Diagnosis and management of osteomyelitis. Am Fam Physician 2002;63(12):2413–2420.
Ceroni D, Regusci M, Pazos JM, Saunders CT, Kaelin A. Risks and complications of prolonged parenteral antibiotic treatment in children with acute osteoarticular infections. Acta Othop Belg 2003;69(5):400–404.
Gillespie WJ, Mayo KM. The management of acute haematogenous osteomyelitis in the antibiotic era: a study of the outcome. J Bone Joint Surg Br 1981;63-B(1):126–131.
Vinod MB, Matusske J, Curtis N, Graham HK, Carapetis JR. Duration of antibiotics in children with osteomyelitis and septic arthritis. J Paediatr Childh Health 2002;38(4):363–367.
Prado SMA, Lizama CM, Pena DA, Valenzuela MC, Viviani ST. Short duration of initial intravenous treatment in 70 pediatric patients with osteoarticular infections. Rev Chilena Infectol 2008;25(1):30–36.
Peltola H, Pääkkönen M, Kallio P, Kallio MJ. Prospective, randomized trial of 10 days versus 30 days of antimicrobial treatment, including a short-term course of parenteral therapy, for childhood septic arhtritis. Clin Infect Dis 2009;48(9):1201–1210.
Peltola H, Pääkkönen M, Kallio P, Kallio MJT. The OM-SA Study Group. Twenty versus 30 Days of antimicrobial including a short course of parenteral therapy for acute hematogenous osteomyeltiis of childhood. A randomized, controlled trial on 131 culture-positive cases. Pediatr Infect Dis J 2010;29(7):716–719.
Abuamara S, Louis JS, Quyard MF, Barbier-Frebourg N, Lechevallier J. Osteoarticular infection in children: evaluation of a diagnostic and management protocol. Rev Chir Orthop Reparatrice Appar Mot 2004;90(8):703–713.
Shetty AK, Gedalia A. Management of septic arthritis. Indian J Pediatr 2004;71(9):819–824.
Jaberi FM, Shahcheragni GH, Ahadzadeh M. Short-term intravenous antibiotic treatment of acute hematogenous bone and joint infections: a prospective randomized trial. J Pediatr Orthop 2002;22(3):317–320.
Eyichykwu GO, Onyemaechi NO, Onyegbule EC. Outcome of management of non-gonococcal septic arthritis at National Orthopaedic Hospital, Enugu, Nigeria. Niger J Med 2010;19(1):69–76.
Kao HC, Huang YC, Chiu CH, Chang LY, Lee ZL, Chung PW, et al. Acute hematogenous osteomyelitis and septic arthritis in children. J Microbio Infect 2003;36(4):260–265.
Ballock RT, Newton PO, Evans SJ, Estabrook M, Farnsworth CL, Bradley JS. A comparison of early versus late conversion from intravenous to oral therapy in the treatment of septic arthritis. J Pediatr Orthop 2009;29(6):636–642.
Uçkay I, Assal M, Legout L, Rohner P, Stern R, Lew D et al. Recurrent osteomyelitis caused by infection with different bacterial strains without obvious source of reinfection. J Clin Micro 2006;44(3):194–196.
Tice AD, Hoaglund PA, Shoultz DA. Risk factors and treatment outcomes in osteomyelitis. J Antim Chemother 2003;51(5):1261–1268.
Harris NH. Some problems in the diagnosis and treatment of acute osteomyelitis. J Bone Joint Surg B. 1960;42-B:535–41.
Dich VQ, Nelson JD, Haltalin KC. Osteomyelitis in infants and children. A review of 163 cases. Am J Dis Child 1975;129(11):1273–1278.
Peltola H, Räsänen JA. Quantitative C-reactive protein in relation to erythrocyte sedimentation rate, fever, and duration of antimicrobial therapy in bacteraemic diseases of childhood. J Infection 1982;5:257–267.
Pääkkönen M, Kallio MJT, Kallio PE, Peltola H. Sensitivity of erythrocyte sedimentation rate and C-reactive protein in childhood bone and joint infections. Clin Orthoped Relat Res 2010;468(3):861–866.
Green JH. Cloxacillin in treatment of acute osteomyelitis. BMJ 1967;2(5549):414–416.
Syrogiannopoulos GA, Nelson JD. Duration of antibiotic therapy for acute suppurative osteoarticular infections. Lancet 1988;1(8575–6):37–40.
Tetzlaff TR, McCracken GH Jr, Nelson JD. Oral antibiotic therapy for skeletal infections of children II. Therapy of osteomyelitis and suppurative arthritis. J Pediatr 1978;92(3):485–490.
Martínez-Aguilar G, Hammerman WA, Mason EO Jr, Kaplan SL. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. J Pediatr Infect Dis 2003;22(7):593–598.
Jagodzinski NA, Kanwar R, Graham K, Bache CE. Prospective evaluation of a shortened regimen of treatment for acute osteomyelitis and septic arthritis in children. J Pediatr Orthop 2009; 29(5):518–525.
Pääkkönen M, Kallio MJT, Peltola H, Kallio PE. Pediatric septic hip with or without arthrotomy retrospective analysis of 62 consecutive nonneonatal culture-positive cases. J Pediatr Orthop B 2010;19(3):264–269
Roine I, Faingezicht I, Arguedas A, Herrera JF, Rodríguez F. Serial serum C-reactive protein to monitor recovery from acute haematogenous osteomyelitis in children. Pediatr Infect Dis J 1995;14(1):40–44.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Pääkkönen, M., Peltola, H. (2012). How Short Is Long Enough for Treatment of Bone and Joint Infection?. In: Curtis, N., Finn, A., Pollard, A. (eds) Hot Topics in Infection and Immunity in Children VIII. Advances in Experimental Medicine and Biology, vol 719. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-0204-6_4
Download citation
DOI: https://doi.org/10.1007/978-1-4614-0204-6_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-0203-9
Online ISBN: 978-1-4614-0204-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)